2022
DOI: 10.1002/anse.202200065
|View full text |Cite
|
Sign up to set email alerts
|

Stimuli‐Responsive RNA‐Cleaving DNAzyme for Biomedical Application

Abstract: Analysis & Sensing www.analysis-sensing.org Review doi.org/10.1002/anse.202200065DNAzymes are synthetic deoxynucleotide oligomers with catalytic properties selected through in vitro systematic evolution of ligands by exponential enrichment (SELEX) technique. RNAcleaving DNAzymes have attracted increasing attentions in bioanalysis and biomedical applications due to their simple synthesis and modification, stable structure, and high catalytic activity. Especially, their different modes of activity regulation ena… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 109 publications
0
3
0
Order By: Relevance
“…Owing to the high catalytic activity and structural identification of DNAzymes, DNAzyme-based DDSs have been widely applied to gene therapy or combined gene therapy by specifically cleaving target mRNA and inhibiting the expression of the corresponding protein. Nevertheless, their low effectiveness in vivo, [96][97][98] arising from low delivery efficiency, instability, and the lack of sufficient cofactors, hinders the development of DNAzymes for clinical application. To address this issue, more attention should be paid to developing DDSs to enhance their cellular uptake, modifications to improve their stability, and smart systems to generate sufficient cofactors in situ.…”
Section: Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…Owing to the high catalytic activity and structural identification of DNAzymes, DNAzyme-based DDSs have been widely applied to gene therapy or combined gene therapy by specifically cleaving target mRNA and inhibiting the expression of the corresponding protein. Nevertheless, their low effectiveness in vivo, [96][97][98] arising from low delivery efficiency, instability, and the lack of sufficient cofactors, hinders the development of DNAzymes for clinical application. To address this issue, more attention should be paid to developing DDSs to enhance their cellular uptake, modifications to improve their stability, and smart systems to generate sufficient cofactors in situ.…”
Section: Reviewmentioning
confidence: 99%
“…To address this issue, more attention should be paid to developing DDSs to enhance their cellular uptake, modifications to improve their stability, and smart systems to generate sufficient cofactors in situ. [96][97][98]…”
Section: Reviewmentioning
confidence: 99%
“…Until now, diverse functions of DNAzymes have been discovered, ranging from DNA and RNA cleavage, DNA phosphorylation, porphyrin metallotransferase, DNA kinase, to DNA capping. [83] Among them, two classes of DNAzyme have been used extensively in the detection of biomarkers: RNA-cleaving DNAzymes (RCDs) and peroxidase mimicking DNAzymes (PMDs). [84,85] RCDs can promote the sitespecific cleavage reaction of an RNA dinucleotide junction, generating two cleavage fragments; PMDs can coordinate with hemin to oxidase substrates, producing colorimetric and chemiluminescent signals when hydrogen peroxide exists.…”
Section: Functional Nucleic Acids For Mediating Precise Sensing React...mentioning
confidence: 99%